Mitochondrial Function is Impaired in Heart Transplant Patients with Cardiac Allograft Vasculopathy

被引：0
|
作者：
Lichscheidt, E. D. [1 ]
Jespersen, N. R. [1 ]
Nielsen, B. R. [1 ]
Berg, K. [1 ]
Botker, H. [1 ]
Eiskjaer, H. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2020年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
196
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [41] When to list for re-do heart transplant in patients with severe cardiac allograft vasculopathy
    Patel, J. K.
    Seid, A.
    Mansukhani, A.
    Thompson, O. M.
    Wu, G. W.
    Laks, H.
    Kobashigawa, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S100 - S101
  • [42] Microvascular dysfunction preceeds epicardial coronary stenosis in heart transplant patients with cardiac allograft vasculopathy
    Osto, E.
    Tona, F.
    Gambino, A.
    Maddalozzo, A.
    Caforio, A. L. P.
    Montisci, R.
    Ramondo, A.
    Gerosa, G.
    Iliceto, S.
    EUROPEAN HEART JOURNAL, 2009, 30 : 157 - 157
  • [43] Sirolimus Therapy and Risk of Late Cellular Rejection in Heart Transplant Patients with Cardiac Allograft Vasculopathy
    Scatola, A.
    Nnani, D.
    Sun, E.
    Alvarez, C.
    Rivas-Lasarte, M.
    Saeed, O.
    Patel, S.
    Sims, D.
    Shin, J.
    Goldstein, D.
    Jorde, U.
    Vukelic, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S278 - S279
  • [44] Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: Does potency matter?
    Sieg, Adam
    Weeks, Phillip
    Krustchinsky, Lori
    Rajapreyar, Indranee
    TRANSPLANTATION REVIEWS, 2016, 30 (03) : 178 - 186
  • [45] PREDICTORS OF ACUTE CELLULAR REJECTION AND ITS ASSOCIATION WITH CARDIAC ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT PATIENTS
    Khalife, W. I.
    Vivo, R. P.
    Garikipati, S.
    Nalabothu, P.
    Johnson, S.
    Kislingbury, K.
    Sharif, R.
    Charif, A.
    CARDIOLOGY, 2013, 125 : 115 - 115
  • [46] Aspirin Use and the Development of Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients
    D'Addese, L.
    Cantor, R.
    Koehl, D.
    Reardon, L.
    Ameduri, R.
    Bock, M.
    Morrison, A.
    White, S.
    Wisotzkey, B.
    Kirklin, J. K.
    Godown, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S119 - S119
  • [47] Impact of Alemtuzumab Induction on Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Recipients
    Plazak, M.
    Gao, X.
    Gale, S.
    Reed, B.
    Madathil, R.
    Hammad, S.
    Ravichandran, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 758 - 759
  • [48] Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients
    Potena, L
    Magelli, C
    Ortolani, P
    Fearon, WF
    Grigioni, F
    Magnani, G
    Coccolo, F
    Yeung, AC
    Luikart, HI
    Hunt, SA
    Mocarski, ES
    Cooke, JP
    Lewis, DB
    Branzi, A
    Valantine, HA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 185A - 185A
  • [49] Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients
    Costanzo, MR
    Koch, DM
    Fisher, SG
    Heroux, AL
    Kao, WG
    Johnson, MR
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (02): : 169 - 178
  • [50] Dipyridamole stress echocardiography for the diagnosis of cardiac allograft vasculopathy in heart transplant recipients
    Alvarez Pichel, I.
    Fernandez Cimadevilla, O. C.
    De la Hera Galarza, J. M.
    Martin Fernandez, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1386 - 1387
12345